Mgo One Seven LLC Abb Vie Inc. Transaction History

Mgo One Seven LLC

$2.26 Billion
Q3 2024

A detailed history of Mgo One Seven LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mgo One Seven LLC holds 26,710 shares of ABBV stock, worth $4.69 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

26,710

Previous 28,625 6.69%

Holding current value

$4.69 Million

Previous $4.91 Million 7.44%

% of portfolio

0.23%

Previous 0.24%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $313,753 - $381,716	-1,915 Reduced 6.69%	26,710 $5.27 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $400,751 - $467,987	2,589 Added 9.94%	28,625 $4.91 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $154,545 - $176,090	-967 Reduced 3.58%	26,036 $4.74 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $532,236 - $599,423	3,868 Added 16.72%	27,003 $4.18 Million
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $317,276 - $367,293	-2,375 Reduced 9.31%	23,135 $3.45 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $2.41 Million - $3 Million	-18,200 Reduced 41.64%	25,510 $3.44 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $2.74 Million - $3.15 Million	18,926 Added 76.36%	43,710 $6.97 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $559,049 - $670,446	4,042 Added 19.49%	24,784 $0
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $96,362 - $110,521	718 Added 3.59%	20,742 $3.43 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $149,868 - $190,531	-1,089 Reduced 5.16%	20,024 $3.07 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $193,350 - $239,893	1,465 Added 7.46%	21,113 $3.42 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $1.14 Million - $1.45 Million	10,651 Added 118.38%	19,648 $2.66 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $593,499 - $673,710	-5,578 Reduced 38.27%	8,997 $1.03 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $41,768 - $46,532	397 Added 2.8%	14,575 $1.64 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $194,881 - $214,541	1,905 Added 15.52%	14,178 $1.53 Million
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $46,201 - $62,376	574 Added 4.91%	12,273 $1.32 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $83,160 - $97,603	968 Added 9.02%	11,699 $1.03 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $336,768 - $450,646	4,590 Added 74.74%	10,731 $1.05 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $55,341 - $83,903	858 Added 16.24%	6,141 $467,000
Q4 2019 Jan 16, 2020	BUY	$72.13 - $90.25 $163,085 - $204,055	2,261 Added 74.82%	5,283 $467,000
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $190,325 - $228,825	3,022 New	3,022 $229,000
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $161,685 - $190,295	-2,096 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $163,173 - $201,236	2,096 New	2,096 $192,000
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $139,233 - $154,783	-1,566 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $3,128 - $4,189	34 Added 2.22%	1,566 $148,000
Q4 2017 Feb 16, 2018	BUY	$89.56 - $98.21 $137,205 - $150,457	1,532	1,532 $148,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account